New Co-STAR Receptor Shows Promise Treating Cancers in Laboratory Study | Naviance

New Co-STAR Receptor Shows Promise Treating Cancers in Laboratory Study

New Co-STAR Receptor Shows Promise Treating Cancers in Laboratory Study

Using genetic engineering techniques, investigators at the Johns Hopkins Kimmel Cancer Center and its Ludwig Center, the Lustgarten Laboratory and Bloomberg~Kimmel Institute for Cancer Immunotherapy have designed a novel type of cell to recognize and fight cancer.

LEARN MORE

Recent Posts

Blocking Energy Metabolism May Help Treat Aggressive Pediatric Brain Tumor This new drug could change how we treat one of the deadliest cancers Inherited Long Telomeres May Drive Broad Risk for Lymphoid Cancers How a Division I athlete who never smoked turned his stage 4 ALK+ lung cancer diagnosis into a fight for a cure Solving a 15-Year Mystery: Scientists Discover How Gut Bacteria Toxin Invades Colon Cells to Trigger Cancer Advances in Treating Women’s Bladder Cancer Elena’s Story: Recurrent Brain Cancer After a year of turmoil, cancer researchers see promising signs for mRNA vaccines AI and Mammograms